Trans Genic Inc. 2342.T Stock
Trans Genic Inc. Price Chart
Trans Genic Inc. 2342.T Financial and Trading Overview
Trans Genic Inc. stock price | 231 JPY |
Previous Close | 306 JPY |
Open | 305 JPY |
Bid | 308 JPY x 0 |
Ask | 309 JPY x 0 |
Day's Range | 305 - 309 JPY |
52 Week Range | 296 - 391 JPY |
Volume | 15.4K JPY |
Avg. Volume | 29.79K JPY |
Market Cap | 5.08B JPY |
Beta (5Y Monthly) | 0.873946 |
PE Ratio (TTM) | 4.1960893 |
EPS (TTM) | -37.4 JPY |
Forward Dividend & Yield | 6 (1.92%) |
Ex-Dividend Date | March 28, 2024 |
1y Target Est | N/A |
2342.T Valuation Measures
Enterprise Value | 4.22B JPY |
Trailing P/E | 4.1960893 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.44468802 |
Price/Book (mrq) | 0.8657208 |
Enterprise Value/Revenue | 0.369 |
Enterprise Value/EBITDA | 26.876 |
Trading Information
Trans Genic Inc. Stock Price History
Beta (5Y Monthly) | 0.873946 |
52-Week Change | -13.31% |
S&P500 52-Week Change | 20.43% |
52 Week High | 391 JPY |
52 Week Low | 296 JPY |
50-Day Moving Average | 308.88 JPY |
200-Day Moving Average | 325.52 JPY |
2342.T Share Statistics
Avg. Volume (3 month) | 29.79K JPY |
Avg. Daily Volume (10-Days) | 48.74K JPY |
Shares Outstanding | 16.45M |
Float | 15.47M |
Short Ratio | N/A |
% Held by Insiders | 8.07% |
% Held by Institutions | 2.81% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 3 |
Trailing Annual Dividend Yield | 0.98% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.040700004 |
Last Split Factor | 100:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | -3.57% |
Operating Margin (ttm) | -0.21% |
Gross Margin | 17.44% |
EBITDA Margin | 1.37% |
Management Effectiveness
Return on Assets (ttm) | -0.14% |
Return on Equity (ttm) | -6.88% |
Income Statement
Revenue (ttm) | 11.43B JPY |
Revenue Per Share (ttm) | 678.53 JPY |
Quarterly Revenue Growth (yoy) | 1.19% |
Gross Profit (ttm) | N/A |
EBITDA | 157M JPY |
Net Income Avi to Common (ttm) | -409000000 JPY |
Diluted EPS (ttm) | 73.64 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.46B JPY |
Total Cash Per Share (mrq) | 205.19 JPY |
Total Debt (mrq) | 2.42B JPY |
Total Debt/Equity (mrq) | 39.47 JPY |
Current Ratio (mrq) | 2.757 |
Book Value Per Share (mrq) | 356.928 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1430000000 JPY |
Levered Free Cash Flow (ttm) | -1026124992 JPY |
Profile of Trans Genic Inc.
Country | Japan |
State | N/A |
City | Fukuoka City |
Address | 2-3-36 Tenjin |
ZIP | 810-0001 |
Phone | 81 9 2288 8470 |
Website | https://www.transgenic.co.jp |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Trans Genic Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. The company produces genetically modified mice, protein hyper-expression cells, and antibodies; provides glycan synthesis/analysis services; and offers non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods and pharmaceutical agents; support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports; and hospital support services. It also offers drug efficiency and pharmacological test and safety studies; sugar chain analysis and synthesis services; advice and support services, including M&A, business revitalization, investment business, and business succession-related services; and contract production services, such as genetically modified mice, antibodies, protein hypers, and expressing cells, as well as sells mouse-related products and mouse models, antibody products, and research reagents. The company was formerly known as Kumamoto Immunochemical Laboratories Inc. and changed its name to Trans Genic Inc. in April 2000. Trans Genic Inc. was incorporated in 1998 and is headquartered in Fukuoka, Japan.
Q&A For Trans Genic Inc. Stock
What is a current 2342.T stock price?
Trans Genic Inc. 2342.T stock price today per share is 231 JPY.
How to purchase Trans Genic Inc. stock?
You can buy 2342.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Trans Genic Inc.?
The stock symbol or ticker of Trans Genic Inc. is 2342.T.
Which industry does the Trans Genic Inc. company belong to?
The Trans Genic Inc. industry is Biotechnology.
How many shares does Trans Genic Inc. have in circulation?
The max supply of Trans Genic Inc. shares is 16.59M.
What is Trans Genic Inc. Price to Earnings Ratio (PE Ratio)?
Trans Genic Inc. PE Ratio is now.
What was Trans Genic Inc. earnings per share over the trailing 12 months (TTM)?
Trans Genic Inc. EPS is -37.4 JPY over the trailing 12 months.
Which sector does the Trans Genic Inc. company belong to?
The Trans Genic Inc. sector is Healthcare.